Form4insider filings, from the source

SEC Form 3 · accession 0000899243-17-021638

Molecular Templates, Inc. · MTEM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
A/S Takeda
10% Owner
Period of report
Aug 1, 2017
Accepted (ET)
Sep 8, 2017 · 11:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001183765

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———2,922,993D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit List: Exhibit 24.1 Power of Attorney for Millennium Pharmaceuticals, Inc.; Exhibit 24.2 Power of Attorney for Takeda Pharmaceuticals U.S.A., Inc.; Exhibit 24.3 Power of Attorney for Takeda Pharmaceuticals International AG; Exhibit 24.4 Power of Attorney for Takeda Pharma A/S; Exhibit 24.5 Power of Attorney for Takeda A/S; Exhibit 24.6 Power of Attorney for Takeda Europe Holdings B.V.